FGF3 and cancer: The specific derivative peptide FP16, designed against FGF3, can inhibit the expression of Cyclin D1 and PCNA, causing the cell cycle to be arrested at the G0/G1 phase, thereby inhibiting the proliferation of cancer cells caused by FGF3 overexpression [66].